Page 474 - Read Online

Saadi et al. Vessel Plus 2020;4:41 I http://dx.doi.org/10.20517/2574-1209.2020.54 Page 13 of 14

valve in low-risk patients. N Engl J Med 2019;380:1695-705.
6. Popma JJ, Deeb GM, Yakubov SJ, et al; Evolut Low Risk Trial Investigators. Transcatheter aortic-valve replacement with a self-
expanding valve in low-risk patients. N Engl J Med 2019;380:1706-15.
7. Reardon MJ, Van Mieghem NM, Popma JJ, et al; SURTAVI Investigators. Surgical or transcatheter aortic-valve replacement in
intermediate-risk patients. N Engl J Med 2017;376:1321-31.
8. Teitelbaum M, Kotronias RA, Sposato LA, Bagur R. Cerebral embolic protection in TAVI: friend or foe. Interv Cardiol 2019;14:22-5.
9. Kroon H, von der Thusen JH, Ziviello F, et al. Heterogeneity of debris captured by cerebral embolic protection filters during TAVI.
EuroIntervention 2020:EIJ-D-20-00744.
10. Mastoris I, Schoos MM, Dangas GD, Mehran R. Stroke after transcatheter aortic valve replacement: incidence, risk factors, prognosis,
and preventive strategies. Clin Cardiol 2014;37:756-64.
11. Eggebrecht H, Schmermund A, Voigtländer T, Kahlert P, Erbel R, Mehta RH. Risk of stroke after transcatheter aortic valve implantation
(TAVI): a meta-analysis of 10,037 published patients. EuroIntervention 2012;8:129-38.
12. Nombela-Franco L, Webb JG, de Jaegere PP, et al. Timing, predictive factors, and prognostic value of cerebrovascular events in a large
cohort of patients undergoing transcatheter aortic valve implantation. Circulation 2012;126:3041-53.
13. Muralidharan A, Thiagarajan K, Van Ham R, et al. Meta-analysis of perioperative stroke and mortality in transcatheter aortic valve
implantation. Am J Cardiol 2016;118:1031-45.
14. Coylewright M, Palmer R, O’Neill ES, Robb JF, Fried TR. Patient-defined goals for the treatment of severe aortic stenosis: a qualitative
analysis. Health Expect 2016;19:1036-43.
15. Armijo G, Nombela-Franco L, Tirado-Conte G. Cerebrovascular events after transcatheter aortic valve implantation. Front Cardiovasc
Med 2018;5:104.
16. Seeger J, Gonska B, Otto M, Rottbauer W, Wöhrle J. Cerebral embolic protection during transcatheter aortic valve replacement
significantly reduces death and stroke compared with unprotected procedures. JACC Cardiovasc Interv 2017;10:2297-303.
17. Giustino G, Mehran R, Veltkamp R, Faggioni M, Baber U, Dangas GD. Neurological outcomes with embolic protection devices in
patients undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis of randomized controlled trials. JACC
Cardiovasc Interv 2016;9:2124-33.
18. Kroon HG, van der Werf HW, Hoeks SE, et al. Early clinical impact of cerebral embolic protection in patients undergoing transcatheter
aortic valve replacement: a two-center registry in the Netherlands. Circ Cardiovasc Interv 2019;12:1-8.
19. Nombela-Franco L, Armijo G, Tirado-Conte G. Cerebral embolic protection devices during transcatheter aortic valve implantation:
clinical versus silent embolism. J Thorac Dis 2018;10:S3604-13.
20. Cubero-Gallego H, Pascual I, Rozado J, et al. Cerebral protection devices for transcatheter aortic valve replacement. Ann Transl Med
2019;7:584.
21. Jobanputra Y, Jones BM, Mohananey D, Fatima B, Kandregula K, Kapadia SR. Cerebral protection devices for transcatheter aortic valve
replacement. Expert Rev Med Devices 2017;14:529-43.
22. Van Mieghem NM, van Gils L, Ahmad H, et al. Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the
randomised MISTRAL-C trial. EuroIntervention 2016;12:499-507.
23. Ndunda PM, Vindhyal MR, Muutu TM, Fanari Z. Clinical outcomes of sentinel cerebral protection system use during transcatheter aortic
valve replacement: a systematic review and meta-analysis. Cardiovasc Revasc Med 2020;21:717-22.
24. Haussig S, Mangner N, Dwyer MG, et al. Effect of a cerebral protection device on brain lesions following transcatheter aortic valve
implantation in patients with severe aortic stenosis: the CLEAN-TAVI randomized clinical trial. JAMA 2016;316:592-601.
25. Kapadia SR, Kodali S, Makkar R, et al; SENTINEL Trial Investigators. Protection against cerebral embolism during transcatheter aortic
valve replacement. J Am Coll Cardiol 2017;69:367-77.
26. Seeger J, Kapadia SR, Kodali S, et al. Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic
valve replacement: a patient-level propensity-matched analysis. Eur Heart J 2019;40:1334-40.
27. Cohen DJ. Cerebral embolic protection and TAVR outcomes: results from the TVT Registry. Presented at: TCT 2020. October 16, 2020.
Available from: https://www.tctmd.com/slide/cerebral-embolic-protection-and-tavr-outcomes-results-tvt-registry. [Last accessed on 1 Dec
2020]
28. Megaly M, Sorajja P, Cavalcante JL, et al. Ischemic stroke with cerebral protection system during transcatheter aortic valve replacement.
JACC Cardiovasc Interv 2020;13:2149-55.
29. Gasior T, Mangner N, Bijoch J, Wojakowski W. Cerebral embolic protection systems for transcatheter aortic valve replacement. J Interv
Cardiol 2018;31:891-8.
30. Baumbach A, Mullen M, Brickman AM, et al. Safety and performance of a novel embolic deflection device in patients undergoing
transcatheter aortic valve replacement: results from the DEFLECT I study. EuroIntervention 2015;11:75-84.
31. Lansky AJ, Schofer J, Tchetche D, et al. A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device
during transcatheter aortic valve implantation: results from the DEFLECT III trial. Eur Heart J 2015;36:2070-8.
32. Simsek C, Schölzel BE, den Heijer P, et al. The rationale of using cerebral embolic protection devices during transcatheter aortic valve
implantation. Neth Heart J 2020;28:249-52.
33. Moses JW. A randomized evaluation of the TriGUARD3 cerebral embolic protection device to reduce the impact of cerebral embolic
lesions after transcatheter aortic valve implantation: the REFLECT II trial. Presented at: TCT 2020. October 15, 2020. Available from:
https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2020/10/14/16/42/REFLECT-II. [Last accessed on 1 Dec 2020]
34. Rodés-Cabau J, Kahlert P, Neumann FJ, et al. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system